X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
This new agreement, which has a term of ten years, includes a series of investments expected to allow the manufacturing capacity of products including Spikevax, to increase across ROVI's facilities in Madrid, Spain.
Lead Product(s): Elasomeran
Therapeutic Area: Infections and Infectious Diseases Product Name: Spikevax
Highest Development Status: ApprovedProduct Type: Vaccine
Partner/Sponsor/Collaborator: Moderna Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Expanded Collaboration February 16, 2022
Details:
As part of the agreement, ROVI will provide vial filling and packaging capacity by procuring a new production line and equipment for compounding, filling, automatic visual inspection and labeling to support production of hundreds of millions of doses of Moderna's mRNA-1273.
Lead Product(s): mRNA-1273
Therapeutic Area: Infections and Infectious Diseases Product Name: mRNA-1273
Highest Development Status: Phase IIIProduct Type: Vaccine
Partner/Sponsor/Collaborator: Moderna Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration July 09, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
